仑伐替尼、PD-1抑制剂联合TACE-HAIC治疗原发性肝癌的临床效果及安全性评估
张恒, 邹玲, 李捷, 刘召洪, 张再华, 殷登菊
The clinical efficacy and safety assessment of lenvatinib and PD-1 inhibitors combined with TACE-HAIC in the treatment of primary liver cancer
Zhang Heng, Zou Ling, Li Jie, Liu Zhaohong, Zhang Zaihua, Yin Dengju
肝脏
.
2026, (7): 989
-993
.
